FPH - Fisher Paykel Healthcare.

[Ttops]

appointment?
application?
apparatus?
appropriate?
apparition...............!!!?

app = Apnea product= "a new mask" my guess anyway

Got to think laterally
The company expects to introduce several additional devices incorporating its new technology over
the next two years. http://stocknessmonster.com/news-ite...=NZSE&N=153170

[beacon]

Meaning continuous promotional expense while rising forex cuts into already wafer thin profits and as the industry gets more competitive by the day. Good luck to Caledonia. To my surprise, I have finally turned bearish on the stock.

[Zaphod]

FPH
11/12/2007
SSH

REL: 1129 HRS Fisher & Paykel Healthcare Corporation Limited

SSH: FPH: SSH Notice From Schroder Investment Management Australia

NOTICE 29555 DETAILS

Submitted Date : 11-Dec-2007 11:24
Status : Accepted

Substantial : Y Director : N
Add Holder : Y Change Holder : N
Ceased Holder : N Change Nature : N

Issuer Code : FPH Fisher & Paykel Healthcare Corporation Limited
Holder : Schroder Investment Management Australia Limited

Address : Level 20 Angel Place
: 123 Pitt Street
: Sydney NSW 2000
Country : Australia

Contact Name : Andrew Arthur
Phone : +61 2 9210 9418

Total of Interest : 29,988,254
Total Issued : 508,663,426
Total % : 5.90%

Class : FPH
Votes Attached : 1

Beneficial
Total of Interest : 0
Names
: N/A
Transaction Dates : N/A
Total Votes : N/A
Considerations : N/A

Non Beneficial
Total of Interest : 29,988,254
Current % held : 5.9%
Last % held : 5.9%
Names : See Annexure A
Provisions : 5(1) (b) and (d)
Transaction dates : As per Annexure B
Total Votes : 29,988,254
Considerations : As per Annexure B

Description : As per Annexure B
Documentation
With Notice : Yes
Not Filed : No
Been Filed : No
Number of pages : 5

Date of Last Notice : N/A
Rel. Sec. Holders : N/A

Submitted By : Andrew Arthur Compliance Officer
End CA:00158072 For:FPH Type:SSH Time:2007-12-11:11:29:04

[beacon]

And to Schroder

[living2]

Philips buys Respironics for €3.6bn
By Michael Steen in Amsterdam

Published: December 21 2007 07:57 | Last updated: December 21 2007 11:28

Philips, the Dutch electronics group, said on Friday it would buy Respironics, the US medical equipment maker specialising in sleep therapy, for €3.6bn ($5.2bn) in cash, its biggest acquisition to date.

The Dutch company, under pressure to reduce its cash pile, has in the last three weeks announced a €5bn share buy-back programme, the €1.8bn acquisition of US lighting fixtures maker Genlyte and two smaller takeovers by its healthcare business.

EDITOR’S CHOICE
Philips in €5bn share buy-back - Dec-19European View: Politicians heed the parable of Pechiney - Nov-27Philips launches €1.8bn bid for Genlyte - Nov-26Philips to miss medical sales forecasts - Oct-15Philips cuts stake in LCD maker - Oct-10Philips to invest €1bn on environmental technology - Sep-25Philips will pay $66 a share for Respironics, a 24 per cent premium on the US group’s closing price on Thursday, valuing the target at 22.5 times 2008 earnings.

Pierre-Jean Sivignon, chief financial officer, said Respironics would form ”the centrepiece” of Philips’ home healthcare business, an area in which it is forecasting strong growth. Gerard Kleisterlee, chief executive, said consumer healthcare hit the ”sweet spot” between Philips’ healthcare and consumer electronics businesses.

Respironics specialises in the treatment of obstructive sleep apnea, a condition involving brief stops in breathing during sleep which is often accompanied by loud snoring and poor sleep and can lead to more serious ailments.

Philips said the $5bn global respiratory market was growing at 10 per cent annually while the $2bn market for sleep apnea management products was likely to grow in the mid-teen percentages.

The company has been stockpiling cash as it withdraws from the semiconductor business to focus on lighting, healthcare and consumer electronics. It had €5.2bn in cash at the end of the third quarter and will generate more from further stake sales and asset disposals.

DE Shaw and Jana Partners, two U.S. hedge funds that hold 1.6 per cent of Philips between them, used an open letter this month to put pressure on the Dutch group to speed up decisions on acquisitions and share buy-backs.

Philips has denied the letter forced its hand, noting that the share buy-back was announced after the Dutch parliament passed favourable changes to Dutch tax law and the takeover plans predated its publication.

”Are we moving to what we called in various releases an efficient balance sheet? The answer is definitely yes,” Mr Sivignon said. He added the company had ”some room” for further acquisitions but needed to integrate the new businesses.

Philips shares slipped 17 cents to €30.54 in mid-morning trading in Amsterdam.
Copyright The Financial Times Limited 2007

[ratkin]

The price rise today is an interesting reaction to the takeover of their main rivals.
Being taken over by Phillips will no doubt make them much stronger , they will now take more market share from Fand P .

i suppose the SP is rising due to the vague notion that another big company will come swooping for f and p. Guess the stock has been percieved as being undervalued of late.

[winner69]

Philips buys Respironics for €3.6bn
By Michael Steen in Amsterdam

...... $66 a share for Respironics, a 24 per cent premium on the US group’s closing price on Thursday, valuing the target at 22.5 times 2008 earnings.

Ratkin suggests FPH up today in response to this move by Phillips

Market must have noted the 22.5 times 2008 earnings ........ ASB show FPH 2008 forecast as 8.3 cents ..... times 22.5 is 186 ..... even on 2007 eps shown as 11.0 gives 247.

Whoops ,,,, so 348 for FPH not too bad at all

[AMR]

Someone has been accumulating since late November, I got my first signal (bullish oscillator divergence) back on the 27th of Nov and I have been getting even more lately. Not too keen to act on them at the moment though, I still think the kiwi dollar has more life in it for now.

Back on watchlist again, might make up my mine in February next year.

[a bowden]

What are peoples views on this stock at them momment, seems to have had a strong few days, would you enter now. Has just broken the 30 day MA. I was thinking of dipping in however am a little concerned that it will just be a short burst.

[Phaedrus]

Hi ab,
I wouldn't pay any attention to the SMA30 crossover if I were you. If we backtest FPH, we find that it is a very poorly performing indicator with this stock. A 30 day simple moving average gives lower returns than simply buying and holding and is wrong (giving losing trades) twice as often as it is right. It "falls between 2 stools" in that it is too long to be of much use for short-term trends and it is too short to be of any use for long-term trends. I have plotted it for you, but its use here is counterproductive. I'm surprised and a little concerned at how many people on ST specifically mention this particular moving average.

You can see from the attached chart that FPH gave multiple buy signals 2 days ago. Anyone buying then bought very close to the current (tentative) trendline and quite close to recent support, making for a low-risk entry point. You can see that buying now would have you entering well above the trendline and maybe 40 cents or more above support. In other words, buying now would give a much higher risk entry, particularly after the series of strong up days that this stock has experienced. We don't know how far FPH will run before it retraces, but it might be better to delay buying until it does. Ideally, it would retrace all the way back to the trendline, confirm it and bounce off in a NNE direction!